Stock-Based Compensation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | 6 Months Ended |
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 |
Stock based compensation by job function [Line Items] | | | | | |
Common Shares Available for Grant | | 28,100 | | 28,100 | |
Compensation expense related to the company's stock-based compensation plans | | $ 28.6 | $ 29.5 | $ 61.7 | $ 65.1 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | 11.7 | 11.7 | 23.3 | 23.7 |
Lease And Well [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 10.5 | 9.1 | 22.6 | 20.7 |
Gathering And Processing Costs [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 0.3 | 0.2 | 0.6 | 0.5 |
Exploration Costs [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 5.9 | 5.6 | 13.3 | 13.5 |
General And Administrative [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 11.9 | $ 14.6 | $ 25.2 | $ 30.4 |
Stock Options and SARs [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 29.78 | $ 27.68 |
Expected Volatility (in hundredths) | | | | 38.93% | 35.15% |
Risk-Free Interest Rate (in hundredths) | | | | 0.82% | 0.86% |
Dividend Yield (in hundredths) | | | | 0.73% | 0.50% |
Expected Life (in years) | | | | 5 years 3 months 18 days | 5 years 2 months 12 days |
Stock Options and SARs Rollforward [Abstract] | | | | | |
Outstanding at January 1 (in shares) | | | | 10,493 | 10,452 |
Granted (in shares) | | | | 39 | 74 |
Exercised (1) (in shares) | [1] | | | (885) | (922) |
Forfeited (in shares) | | | | (177) | (185) |
Outstanding at June 30 (2) (in shares) | [2] | 9,470 | 9,419 | 9,470 | 9,419 |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 64.96 | $ 54.43 |
Granted (price per share) | | | | 92.37 | 92.51 |
Exercised (1) (price per share) | [1] | | | 48.30 | 43.76 |
Forfeited (price per share) | | | | 79.43 | 62.02 |
Outstanding at June 30 (2) (price per share) | [2] | $ 66.36 | $ 55.62 | $ 66.36 | $ 55.62 |
Stock Options and SARs Vested or Expected to Vest (in shares) | [3] | 8,987 | 8,985 | 8,987 | 8,985 |
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) | [3] | $ 65.56 | $ 55.22 | $ 65.56 | $ 55.22 |
Stock Options and SARs Exercisable at June 30 (in shares) | [4] | 4,635 | 3,898 | 4,635 | 3,898 |
Stock Options and SARs Exercisable at June 30 (price per share) | [4] | $ 50.92 | $ 44.71 | $ 50.92 | $ 44.71 |
Intrinsic value of stock options/SARs exercised during the period | [1] | | | $ 39.1 | $ 52.5 |
Aggregate intrinsic value for outstanding stock options and SARs | [2] | $ 229.5 | $ 576.8 | $ 229.5 | $ 576.8 |
Weighted average remaining contractual life for stock options/SARs outstanding (in years) | | | | 3 years 10 months 24 days | 4 years 2 months 12 days |
Aggregate intrinsic value of stock options/SARs vested or expected to vest | [3] | 223.6 | 553.8 | $ 223.6 | $ 553.8 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | | | | 3 years 10 months 24 days | 4 years 2 months 12 days |
Aggregate intrinsic value for exercisable units | [4] | 170.9 | 281.3 | $ 170.9 | $ 281.3 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | | | | 2 years 7 months 6 days | 2 years 9 months 18 days |
Unrecognized compensation expense | | 87.1 | | $ 87.1 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 2 months 12 days | |
ESPP [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 23.39 | $ 18.30 |
Expected Volatility (in hundredths) | | | | 37.47% | 25.83% |
Risk-Free Interest Rate (in hundredths) | | | | 0.11% | 0.09% |
Dividend Yield (in hundredths) | | | | 0.72% | 0.40% |
Expected Life (in years) | | | | 6 months | 6 months |
Restricted Stock and Restricted Stock Units [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Unrecognized compensation expense | | 171.7 | | $ 171.7 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 4 months 24 days | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 16.5 | $ 16.8 | $ 37.7 | $ 39.5 |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 5,394 | 7,358 |
Granted (in shares) | | | | 456 | 435 |
Released (in shares) | [5] | | | (593) | (1,939) |
Forfeited (in shares) | | | | (130) | (181) |
Outstanding at June 30 (1) (in shares) | [6] | 5,127 | 5,673 | 5,127 | 5,673 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 64.39 | $ 49.54 |
Granted (price per share) | | | | 88.29 | 94.73 |
Released (price per share) | [5] | | | 54.85 | 36.85 |
Forfeited (price per share) | | | | 74.13 | 58.48 |
Outstanding at June 30 (1) (price per share) | [6] | $ 67.37 | $ 57.06 | $ 67.37 | $ 57.06 |
Intrinsic value of restricted stock and restricted stock units released during the year | [5] | | | $ 53.9 | $ 207 |
Aggregate intrinsic value of stock and units outstanding | [6] | $ 448.9 | $ 662.9 | 448.9 | $ 662.9 |
Performance Units and Performance Stock [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Unrecognized compensation expense | | $ 4.7 | | $ 4.7 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 3 years | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 333 | 261 |
Granted (in shares) | | | | 0 | 0 |
Released (in shares) | | | | 0 | 0 |
Forfeited (in shares) | | | | 0 | 0 |
Outstanding at June 30 (1) (in shares) | [7] | 333 | 261 | 333 | 261 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 90.17 | $ 82.18 |
Granted (price per share) | | | | 0 | 0 |
Released (price per share) | | | | 0 | 0 |
Forfeited (price per share) | | | | 0 | 0 |
Outstanding at June 30 (1) (price per share) | [7] | $ 90.17 | $ 82.18 | $ 90.17 | $ 82.18 |
Aggregate intrinsic value of stock and units outstanding | [7] | $ 29.2 | $ 30.5 | $ 29.2 | $ 30.5 |
Performance Units and Performance Stock [Abstract] | | | | | |
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost | | $ 0.4 | $ 1 | $ 0.7 | $ 1.9 |
| |
[1] | The total intrinsic value of stock options/SARs exercised for the six months ended June 30, 2015 and 2014 was $39.1 million and $52.5 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at June 30, 2015 and 2014 was $229.5 million and $576.8 million, respectively. At June 30, 2015 and 2014, the weighted average remaining contractual life was 3.9 years and 4.2 years, respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at June 30, 2015 and 2014 was $223.6 million and $553.8 million, respectively. At June 30, 2015 and 2014, the weighted average remaining contractual life was 3.9 years and 4.2 years, respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at June 30, 2015 and 2014 was $170.9 million and $281.3 million, respectively. At June 30, 2015 and 2014, the weighted average remaining contractual life was 2.6 years and 2.8 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released for the six months ended June 30, 2015 and 2014 was $53.9 million and $207.0 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at June 30, 2015 and 2014 was $448.9 million and $662.9 million, respectively. | |
[7] | The total intrinsic value of performance units and performance stock outstanding at June 30, 2015 and 2014 was $29.2 million and $30.5 million, respectively. | |